Do Cannabinoids Help with the Treatment of Alzheimer's Disease? | cannabisMD

Do Cannabinoids Help with the Treatment of Alzheimer’s Disease?

Cannabinoids and Alzheimers

The leading cause for dementia amongst aged individuals is known to be the Alzheimer’s disease, and the cases for this particular disease are expected to rise exponentially over the next fifty years. Appropriate treatments are being developed in order to improve the quality of the patient’s life and to reduce the costs associated with the long and short term treatment dementia. This study aims to evaluate the effects of marijuana on the individuals suffering from Alzheimer’s disease, and how it can help in improving the symptoms and preventing further memory loss.

How medical marijuana prevents the disease from progressing further

The effects of Marijuana on this disease have been studied and it has been found that an active compound in Marijuana, known as the THC, helps in inhibiting the key enzyme, AChE, associated with the Alzheimer’s disease. In an attempt to find a better treatment option, the effects of the THC molecule were observed in various experiments to see how it binds.

Here is the full scientific article if you wish to download it.

Cannabis treatments may have a positive effect on Alzheimer’s patients

Medical Cannabis is a natural product that has anti-inflammatory, anti-emetic, analgesic and anti-convulsive properties. Due to these properties, the THC present in Marijuana is able to bind to the cannabinoid receptors that are present in the body. Medical Cannabis has the ability to affect the pathology of the disease by preventing the neurotransmitters from breaking down, which helps in treating the symptoms as well as preventing the disease from progressing further in alzheimer patients

Cannabis oil may prove to be a better treatment option than most prescription drugs

THC has been found to be a lot more effective in halting the progression of this devastating disease in comparison to the drugs that are normally prescribed for the treatment of Alzheimer’s. The experiments revealed that it effectively inhibits and blocks the effects of the enzymes associated with the disease, which prevents the disease form aggravating further better than the drugs being prescribed today, such as tacrine and donepezil that had reduced the effects of the disease by only 7% and 22% during the study.

Jonathan Neilly
Jonathan Neilly
Jonathan Neilly is registered with the British Psychological Society, breaking the taboo on mental health issues is one of the driving forces in his life. His background in biomedicine gives him additional understanding of the factors that work together to influence the human condition.

Leave a Reply

Your email address will not be published. Required fields are marked *